the
therapeutic possibilities for pituitary adenomas.
Beylerli, O.A.,
Azizova, S.T.,
Konovalov, N.A.,
Akhmedov, A.D.,
Gareev, I.F.,
Belogurov, A.A. (2020) and their potential use as
targets for the treatment of consequences of spinal cord injury. © 2020, Media Sphera
BEYLERLI, OZAL,
BEERAKA, NARASIMHA M.,
GAREEV, ILGIZ,
PAVLOV, VALENTIN,
YANG, GUANG,
LIANG, YANCHAO,
ALIEV, GJUMRAKCH (2020) single-stranded RNA molecules that can influence post-transcriptional regulation by controlling
targetCAI, B.,
MA, W.,
WANG, X.,
SUKHAREVA, N.,
HUA, B.,
ZHANG, L.,
LI, X.,
LI, S.,
LIU, S.,
YU, M.,
XU, Y.,
SONG, R.,
XU, B.,
YANG, F.,
HAN, Z.,
DING, F.,
HUANG, Q.,
YU, Y.,
ZHAO, Y.,
WANG, J.,
BAMBA, D.,
PAN, Z.,
YANG, B.,
XU, J.,
ZAGIDULLIN, N.,
LI, F.,
TIAN, Y. (2020) DACH1 silencing-induced cardiomyocyte proliferation. In addition,
targeting a conserved fragment of Lnc
Длинные некодирующие РНК: какие перспективы? biomarkers and
therapeutic targets for cancer. This review summarizes current knowledge about the biology
LIU, W.,
ZHUANG, R.,
BAI, X.,
JIA, Z.,
KAPORA, E.,
TAN, W.,
FENG, S. (2020) (lncRNAs) have been proposed as
therapeutic targets in CC. Hence, the present study evaluated
Larionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) as biomarkers and
therapeutic targets to develop cancer-specific immunotherapy and to design efficient
Zhang, Lu,
Wang, Yi-ning,
Ju, Jia-ming,
Shabanova, Azaliia,
Li, Yue,
Fang, Ruo-nan,
Sun, Jia-bin,
Guo, Ying-ying,
Jin, Tong-zhu,
Liu, Yan-yan,
Li, Tian-yu,
Shan, Hong-li,
Liang, Hai-hai,
Yang, Bao-feng (2020) mitochondrial function and reducing inflammatory signaling pathways, implying a promising
therapeutic target